lifestyle.thedishh.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Calidi Biotherapeutics, Inc
Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering
March 6, 2026
Calidi Biotherapeutics Announces Proposed Public Offering
March 5, 2026
Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference
February 20, 2026
Calidi Biotherapeutics To Present on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform in a Late-Breaking Abstract at the 2026 AACR-IO Conference
February 12, 2026
Calidi Biotherapeutics Provides Corporate Update and Key Value Drivers for 2026
January 28, 2026